I am the founder of the Law Offices of Alan J. Morrison in New York.  Prior to that, I was a partner at the New York firms of Cozen O’Connor, Cohen, Pontani, Lieberman & Pavane LLP and Cooper & Dunham LLP, and I served as in-house counsel at Johnson & Johnson in New Brunswick, New Jersey.

I counsel my clients in the biotechnology and pharmaceutical fields regarding patents and related transactional law.  In that regard, I have considerable experience drafting opinions on patent infringement and invalidity, as well as patentability, inventorship, inequitable conduct, and the Hatch-Waxman Act.  My experience also encompasses performing patent portfolio analyses, and preparing and negotiating pharmaceutical and biotechnology contracts.  These contracts include patent licenses, joint development agreements, research collaboration agreements, feasibility study agreements and technology transfer agreements.

Since my practice began, I have engaged in all aspects of U.S. and international patent prosecution in the biotechnology and pharmaceutical fields.  I have represented corporations, universities and research institutes in protecting groundbreaking inventions such as recombinant antibody drugs, catalytic nucleic acids, DNA microarrays, diagnostic methods and kits, pharmaceutical formulations, stem cell-based methods, and small molecule drug synthesis.

In my more than 20 years of practice, I have represented some of the world’s largest, most prestigious and most innovative companies and institutions, and have been selected as a Super Lawyer by Super Lawyers® of Thomson Reuters.  I have counseled CEO’s, venture capitalists and Nobel laureates, and have aided my clients in matters exceeding a billion dollars in value.

In addition to practicing law, I teach a graduate course in biotechnology law at Columbia University, where I am an adjunct faculty member in the Department of Biological Sciences.  The course, which I designed, is the first of its kind at Columbia.

I have also lectured extensively in the United States, Europe, Asia and Africa on various topics in patent and regulatory law, and have written and spoken on timely and often controversial topics such as gene patenting and biosimilars law. 

I am co-chair emeritus and a founding member of the advisory board for the Bellevue/NYU Program for Survivors of Torture.  I have also served on the advisory boards for the Stem Cell Partnering Series and the Columbia University Biotechnology Association.  Before studying law, I studied Chinese at the Beijing Language Institute in China.

I earned my B.A. in biochemistry from the University of California, Berkeley, in 1984.  I earned my M.S. in biological chemistry from the University of Michigan in 1986, and my M.Phil. in biochemistry and molecular biophysics from Columbia University in 1988.  I earned my J.D. from Yeshiva University in 1992.

 

Recent Papers and Presentations

The U.S. Supreme Court’s AMP v. Myriad Decision, and its Ethical Implications, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 25, 2014 (Sole Lecturer). 

Protecting Biotechnology in an Era of Judicial Hostility, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, January 30, 2014 (Sole Lecturer).

Alan J. Morrison and Richard T. RuzichGunn v. Minton and the Patent Malpractice Case, Intellectual Property Magazine, October 2013, 62-63.

The Ethics of Reverse Payment Agreements between Brand Name and Generic Drug Companies under the Hatch-Waxman Act and The U.S. Supreme Court and the Future of Human Gene Patents, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 24, 2013 (Sole Lecturer).

Alan J. Morrison, Protecting Your Patents by Getting Inventorship Right, Cozen O’Connor Business Law Observer, Winter 2013.  

Protecting Biotechnology Inventions, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, January 31, 2013 (Sole Lecturer).

The U.S. Patent: An Update, presented at the Beijing Foreign Studies University Law School, Beijing, China, April 9, 2012 (Sole Lecturer). 

Biotechnology Patent Protection in the United States, presented at the Seminar on Special Topics in Exploring Anhui Province’s Corporate Investment and Development Opportunities in the United States, held under the auspices of the Anhui Provincial Government’s Development Research Center, Hefei City, Anhui Province, China, April 7, 2012 (Lecturer).

The Bioethics of DNA Patents and Pay-for-Delay Schemes, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, February 8, 2012 (Sole Lecturer).

Intellectual Property Law for Biotechnology, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 2, 2012 (Sole Lecturer).

The New Waiting Game: Biosimilar Drugs and the 12-Year Exclusivity Period, presented as part of the Symposium on Access to Essential Medicines, Biotechnology Patents, and Global Cooperation, Temple University, Beasley School of Law, Philadelphia, Pennsylvania, April 1, 2011 (Lecturer). 

The Bioethics of Gene Patents, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, February 16, 2011 (Sole Lecturer). 

Special Topics in Biotechnology Law, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 8, 2011 (Sole Lecturer).

Introduction to Intellectual Property for the Biosciences, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 3, 2011 (Sole Lecturer).

Alan J. Morrison, Rethinking the Gene Patent, Biotechnology Law Report. December 2010, 29(6): 609-614. 

Podcast interview of Alan J. Morrison by Doris Gilman of Health Thought Leadership One-to-One, November 1, 2010, providing an introduction to the topic of gene patents.

Should Genes Be Patented?, a panel discussion with Dr. Wendy Chung, Alan J. Morrison, Esq. and Dr. John Loike, presented at Columbia University and hosted by Columbia Technology Ventures, New York, New York, April 28, 2010 (Panelist).

Challenging the Biotech Patent: The ACLU Takes on Myriad Genetics and the U.S. Patent Office, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 9, 2010 (Lecturer).

IP Issues in the Therapeutic Antibody Industry (Chapter 39 of Antibody Engineering), United States subchapter of Patent Enforcement (39.4.13), Springer-Verlag Berlin Heidelberg, 2010 (Contributor).

What Price Biosimilars? Balancing the Innovation and Cost of Biologics in America, presented at Biologic India 2009, Mumbai, India, December 2, 2009 (Lecturer).

Understanding the U.S. Biotechnology Patent, presented at Sun Yat-Sen University, Guangzhou, China, June 16, 2009 (Sole Lecturer).

Selected Developments in U.S. Biotech Patent Law - 2009, presented at the Workshop on Biotechnology Patent Law, hosted by Michalski Hüttermann and Partner, Düsseldorf, Germany, May 5, 2009 (Lecturer).

Understanding the Biotechnology Patent, presented to the Master’s Program in Biotechnology, Columbia University, New York, New York, March 11, 2009 (Sole Lecturer). 

Ethical Issues Concerning Human Embryonic Stem Cell Patents, presented at the second annual meeting of The Stem Cell Partnering Series, held at the University of California, San Diego, La Jolla, California, February 27, 2009 (Lecturer and Meeting Co-Chair).

Selected Thoughts on Legal Writing in Patent Law, presented to The Scientific Patent Law Group in New York and The New York Academy of Sciences, held at The New York Academy of Sciences, February 19, 2009 (Sole Lecturer).

Alan J. Morrison, Patenting DNA in the United States, Managing Intellectual Property (December 2008/January 2009).